<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03733873</url>
  </required_header>
  <id_info>
    <org_study_id>Suoquan in MNE</org_study_id>
    <nct_id>NCT03733873</nct_id>
  </id_info>
  <brief_title>Study on Chinese and Western Medicine in MNE Children</brief_title>
  <official_title>Study on the Therapeutic Schedule and Mechanism of Suoquan Mixture Combined With Desmopressin to Children's Monosymptomatic Enuresis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital of Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital of Fudan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Monosymptomatic nocturnal enuresis (MNE) is a common pediatric developmental disorder. MNE
      refers to urinary incontinence in the sleep state in children aged ≥5 years, without other
      LUT symptoms, and without bladder dysfunction. Its pathogenesis mainly include overnight
      polyuria, overactive bladder, sleep-arousal dysfunction, genetics, and abnormal secretion of
      anti-diuretic hormone (ADH). Desmopressin is a synthetic analog of ADH arginine-vasopressin
      (AVP), which is used to treat central diabetes insipidus and primary nocturnal enuresis
      (PNE). Desmopressin decreases urine production at night when taken at bedtime. Insufﬁcient
      ADH secretion at night will contribute to nocturnal polyuria, which is an important cause of
      NE. Therefore, desmopressin, a synthetic analog of ADH, is frequently used for NE and is an
      evidence-based therapy (grade ⅠA evidence). Some children, however, have desmopressin
      resistance and do not achieve the desired treatment goals. What's more,there's a high relapse
      rate of desmopressin after withdrawing. Suoquan mixture is a Chinese medicine commonly used
      to treat NE in children. It is composed of Cuscuta, Codonopsis, Psoralea corylifolia Linn
      ,Astragalus,mantis egg-case and ephedra. It has not only a certain cure rate but also has a
      lower relapse rate . However there's few evidence could prove that. In this study,the
      investigators compared the 3 month treatment response and relapse rate (RR) in the following
      6 months of desmopressin and desmopressin plus suoquan, and observe if there will be a lower
      relapse rare in desmopressin plus Suoquan. Moreover, the investigators will try to explore
      the mechanism of Suoquan mixture in MNE.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 14, 2019</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">November 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>group1 desmopressin group2 desmopressin plus Suoquan mixture</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the relapse rate of MNE</measure>
    <time_frame>in 6 months after stopping drugs</time_frame>
    <description>If Suoquan mixture plus desmopressin could reduce the relapse rate of MNE</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Monosymptomatic Nocturnal Enuresis</condition>
  <arm_group>
    <arm_group_label>desmopressin plus Suoquan</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Drug1. name:desmopressin form:tablet dosage:2-4mg frequency:qn duration:3 months Drug2 name:Suoquan mixture form:liquid dosage:10ml/time frequence:bid duration:3 months</description>
  </arm_group>
  <arm_group>
    <arm_group_label>desmopressin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>name:desmopressin form:tablet dosage:2-4mg frequency:qn duration:3 months</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desmopressin</intervention_name>
    <description>take desmopressin for 3 months</description>
    <arm_group_label>desmopressin</arm_group_label>
    <arm_group_label>desmopressin plus Suoquan</arm_group_label>
    <other_name>Minirin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Suoquan</intervention_name>
    <description>take Suoquan mixture for 3 months</description>
    <arm_group_label>desmopressin plus Suoquan</arm_group_label>
    <other_name>Suoquan mixture</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  bedwetting occured ≥2nights/week,last for at least 3 months

          -  without other LUT symptoms

          -  without bladder dysfunction.

          -  no treatment in last 3 months

          -  signed the consent

        Exclusion Criteria:

          -  had other LUT symptoms

          -  with bladder dysfunction

          -  had treatment in last 3 months

          -  without the consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hong Xu, MD.PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Children's Hospital of Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hong Xu, MD.PhD.</last_name>
    <phone>+8602164931120</phone>
    <phone_ext>+8602164931120</phone_ext>
    <email>hxu@shmu.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children's hospital of Fudan university</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hong Xu, MD.PhD.</last_name>
      <phone>+8602164931120</phone>
      <email>hxu@shmu.edu.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 6, 2018</study_first_submitted>
  <study_first_submitted_qc>November 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 7, 2018</study_first_posted>
  <last_update_submitted>November 8, 2019</last_update_submitted>
  <last_update_submitted_qc>November 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital of Fudan University</investigator_affiliation>
    <investigator_full_name>Hong Xu，MD.PhD</investigator_full_name>
    <investigator_title>chief physician</investigator_title>
  </responsible_party>
  <keyword>nocturnal enuresischildren</keyword>
  <keyword>Chinsese medicine</keyword>
  <keyword>children</keyword>
  <keyword>relapse rate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Enuresis</mesh_term>
    <mesh_term>Urinary Incontinence</mesh_term>
    <mesh_term>Nocturnal Enuresis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deamino Arginine Vasopressin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

